Nicolas Desbaillets
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- COVID-19 and healthcare impacts
Papers in
- Co-authors
- Andreas Felix Hottinger (4 shared papers)Pierre Dessen (1 shared paper)Eleftheria Kampouri (1 shared paper)Petr Szturz (1 shared paper)Bernhard Gentner (1 shared paper)Blanca Navarro (1 shared paper)Vincent Dunet (1 shared paper)Joerg Huelsken (1 shared paper)
- Journals
- Cancers (2 papers)The Lancet (1 paper)Frontiers in Immunology (1 paper)Current Opinion in Neurology (1 paper)Molecular Therapy (1 paper)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Nicolas Desbaillets
6 papers receiving 384 citations
Nicolas Desbaillets's Hit Papers
Peers
Comparison fields: 5 of 53
- Infectious Diseases 227
- Oncology 66
- Genetics 20
- Neurology 12
- Toxicology 4
Countries citing papers authored by Nicolas Desbaillets
This map shows the geographic impact of Nicolas Desbaillets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Desbaillets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Desbaillets more than expected).
Fields of papers citing papers by Nicolas Desbaillets
This network shows the impact of papers produced by Nicolas Desbaillets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Desbaillets. The network helps show where Nicolas Desbaillets may publish in the future.
Co-authors
The 12 scholars most cited alongside Nicolas Desbaillets, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 2 | 2019 | 63 | |
| 3 | 2021 | 24 | |
| 4 | 2023 | 11 | |
| 5 | 2024 | 3 | |
| 6 | 2015 | 1 | |
| 7 | 2026 | 0 |
About Nicolas Desbaillets
Nicolas Desbaillets is a scholar working on Oncology, Genetics, Neurology, Infectious Diseases and Immunology, having authored 7 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), COVID-19 Clinical Research Studies (1 paper), Cancer Cells and Metastasis (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper), CAR-T cell therapy research (1 paper), Tuberous Sclerosis Complex Research (1 paper), Immunotherapy and Immune Responses (1 paper) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (227 citations), Oncology (66 citations), Genetics (20 citations), Neurology (12 citations) and Toxicology (4 citations). Nicolas Desbaillets has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Andreas Felix Hottinger, Pierre Dessen, Eleftheria Kampouri, Petr Szturz, Bernhard Gentner, Blanca Navarro, Vincent Dunet, Joerg Huelsken, Angela Koutsokera and Lionel Trueb. Their work appears in journals such as Cancers, The Lancet, Frontiers in Immunology, Current Opinion in Neurology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.